Eli Lilly's Medicaid rebate payments under fire as whistleblower lawsuit heads to trial

Eli Lilly is headed to trial over claims it skimped on Medicaid rebate payments.

U.S. District Judge Harry Leinenweber has shot down Lilly’s motion to end a 2014 whistleblower lawsuit, concluding that the Indianapolis-based pharma previously misled the Centers for Medicare & Medicaid Services (CMS) about the prices it charged distributors for its drugs.